Dialpad Raises Additional $10M from SoftBank Corp. to Accelerate Product Expansion in Japan and APAC
Dialpad expands footprint in APAC, empowering global workforces with Voice Intelligence through its AI-powered cloud…
5 years ago
Blue Yonder Named a Great Place to Work®
Company now recognized as a Great Place to Work Certified™ in the U.S. and India…
5 years ago
Arista Unveils Attack Surface Assessment Service
Delivers AI-driven advanced threat hunting and incident response expertise SANTA CLARA, Calif.--(BUSINESS WIRE)--Arista Networks (NYSE:ANET)…
5 years ago
DHL Delivers First Batch of COVID-19 Vaccines to Singapore
Rigorous planning and testing to ensure supply chain supports vaccine's stringent temperature requirements SINGAPORE -…
5 years ago
HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA to Access Compounds for Potential Development of a Novel Class of Drugs
CHENGDU, China--(BUSINESS WIRE)--HitGen Inc. is pleased to announce that HitGen and Merck & Co., Inc.,…
5 years ago
Propanc Biopharma Receives First Granted Patent for Method to Treat Cancer Stem Cells from Australian Patent Office
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing…
5 years ago
First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the first two patients in the world have been…
5 years ago
Middleby Acquires United Foodservice
ELGIN, Ill.--(BUSINESS WIRE)--The Middleby Corporation (NASDAQ: MIDD) today announced the acquisition of Zhuhai Guangdong China-based…
5 years ago
Azura Ophthalmics Announces Primary Endpoints Met in Topline Results from Phase 2 Trial of the Company’s Investigational Treatment for Contact Lens Discomfort
Significant improvement in multiple measures of Meibomian gland secretion and associated improvements in contact lens…
5 years ago
Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy
WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other…
5 years ago